Blog
RSS FeedPosted by Michael Wonder on 12 Dec 2018
Health organisations join calls for a review into government drug buying agency
12 December 2018 - Pressure is mounting on the government to announce a review into its drug buying agency with ...
Posted by Michael Wonder on 11 Dec 2018
Glatect added to public drug plan in British Columbia as sole RRMS treatment of its type
11 December 2018 - Pendopharm’s Glatect (glatiramer acetate) — a treatment for patients with relapsing-remitting multiple sclerosis — has been added ...
Posted by Michael Wonder on 11 Dec 2018
Labor kickstarts inquiry into private health insurance
11 December 2018 - Labor will fast-track its promised inquiry into private health insurance, calling for submissions before the federal ...
Posted by Michael Wonder on 11 Dec 2018
Decision to list a new brand of iron polymaltose (Ferrosig)
11 December 2018 - PHARMAC is pleased to announce a decision to list a new brand of iron polymaltose inj ...
Posted by Michael Wonder on 10 Dec 2018
Perjeta given green light in Scotland as early stage breast cancer treatment
10 December 2018 - Hundreds of breast cancer patients are expected to benefit after a sought-after drug was approved for ...
Posted by Michael Wonder on 10 Dec 2018
SMC - December 2018 decisions
10 December 2018 - A medicine used to treat early stage breast cancer has been accepted by the SMC for ...
Posted by Michael Wonder on 10 Dec 2018
NICE turns down Opdivo/Yervoy combo for kidney cancer
10 December 2018 - NICE has published draft guidelines rejecting NHS funds for Opdivo/Yervoy for untreated metastatic renal cell carcinoma. ...
Posted by Michael Wonder on 10 Dec 2018
Tech giants waiting in wings to give health care a shake-up
10 December 2018 - Tech giants see health care as a new area for growth. ...
Posted by Michael Wonder on 10 Dec 2018
Health insurance cap may advantage youth
10 December 2018 - Bill Shorten has accused the industry of “treating Australians like mugs, gouging people on the basis of ...
Posted by Michael Wonder on 10 Dec 2018
Breast cancer sufferer fighting for life-extending drugs wants PHARMAC inquiry
10 December 2018 - A woman fighting stage 4 breast cancer is a "little shy" of the $77,000 she needs ...
Posted by Michael Wonder on 10 Dec 2018
Pharma calls for more detail on plan for post Brexit medicines access
10 December 2018 - The pharmaceutical industry is calling on the government to urgently provide more detail on how it ...
Posted by Michael Wonder on 10 Dec 2018
Proposal to open access to atomoxetine and change funded brand
10 December 2018 - PHARMAC is proposing to remove all funding restrictions from all presentations of atomoxetine, and change the ...
Posted by Michael Wonder on 09 Dec 2018
Transparency Commission publishes its opinion for Yescarta
7 December 2018 - Opinion published following an examination of written submissions on 5 December 2018. ...
Posted by Michael Wonder on 08 Dec 2018
AMNOG as a learning system: new study on ingenol mebutate in actinic keratosis shows added benefit
3 December 2018 - Advantage over diclofenac in complete clearance of visible lesions / unclear sustainability of treatment effect ...
Posted by Michael Wonder on 07 Dec 2018
NICE OKs NHS funding for Gilead’s CAR T-cell therapy
7 December 2018 - Gilead’s CAR T-cell therapy Yescarta will be available on the NHS to some adults with lymphoma. ...